Patents by Inventor Walid M. Abi-Saab

Walid M. Abi-Saab has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20140296493
    Abstract: The invention describes methods of treating depression comprising administering a TNF? antibody, such as a human TNF? antibody.
    Type: Application
    Filed: February 5, 2014
    Publication date: October 2, 2014
    Applicant: ABBVIE BIOTECHNOLOGY LTD.
    Inventors: Rebecca S. Hoffman, Michael W. Decker, Ana M. Basso, Lynne E. Rueter, Walid M. Abi-saab
  • Patent number: 8222278
    Abstract: 3-(5,6-Dichloro-pyridin-3-yl)-1S,5S-3,6-diazabicyclo[3.2.0]heptane and salts thereof are effective nicotinic receptor agonist compounds that demonstrated pharmacological effect for symptoms associated with attention-deficit/hyperactivity disorder.
    Type: Grant
    Filed: May 29, 2009
    Date of Patent: July 17, 2012
    Assignee: Abbott Laboratories
    Inventors: Earle E. Bain, Walid M. Abi-Saab, Sandeep Dutta, Tushar S. Garimella, Walid M. Awni, Mario D. Saltarelli
  • Publication number: 20100144795
    Abstract: 3-(5,6-Dichloro-pyridin-3-yl)-1S,5S-3,6-diazabicyclo[3.2.0]heptane and salts thereof are effective nicotinic receptor agonist compounds that demonstrated pharmacological effect for symptoms associated with attention-deficit/hyperactivity disorder.
    Type: Application
    Filed: May 29, 2009
    Publication date: June 10, 2010
    Applicant: ABBOTT LABORATORIES
    Inventors: Earle E. Bain, Walid M. Abi-Saab, Sandeep Dutta, Tushar S. Garimella, Walid M. Awni, Mario D. Saltarelli